Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient
Abstract Pulmonary embolism has a high frequency in COVID‐19 patients admitted to the intensive care unit. Low level of fibrinolysis is one of the asserted contributors to a prothrombotic state in COVID‐19. Thrombotic coagulopathy is mostly encountered as diffuse pulmonary thrombi. Diffuse pulmonary...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7116 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850114744485150720 |
|---|---|
| author | Yucel Colkesen |
| author_facet | Yucel Colkesen |
| author_sort | Yucel Colkesen |
| collection | DOAJ |
| description | Abstract Pulmonary embolism has a high frequency in COVID‐19 patients admitted to the intensive care unit. Low level of fibrinolysis is one of the asserted contributors to a prothrombotic state in COVID‐19. Thrombotic coagulopathy is mostly encountered as diffuse pulmonary thrombi. Diffuse pulmonary microemboli was treated successfully with reduced dose thrombolysis. |
| format | Article |
| id | doaj-art-280bac3be19140c49c116e593f44aae0 |
| institution | OA Journals |
| issn | 2050-0904 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj-art-280bac3be19140c49c116e593f44aae02025-08-20T02:36:46ZengWileyClinical Case Reports2050-09042023-03-01113n/an/a10.1002/ccr3.7116Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patientYucel Colkesen0Department of Cardiology Erdem Hospital Istanbul TurkeyAbstract Pulmonary embolism has a high frequency in COVID‐19 patients admitted to the intensive care unit. Low level of fibrinolysis is one of the asserted contributors to a prothrombotic state in COVID‐19. Thrombotic coagulopathy is mostly encountered as diffuse pulmonary thrombi. Diffuse pulmonary microemboli was treated successfully with reduced dose thrombolysis.https://doi.org/10.1002/ccr3.7116alteplasecomputed tomographyCOVID‐19diffuse pulmonary microthrombipulmonary embolism |
| spellingShingle | Yucel Colkesen Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient Clinical Case Reports alteplase computed tomography COVID‐19 diffuse pulmonary microthrombi pulmonary embolism |
| title | Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient |
| title_full | Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient |
| title_fullStr | Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient |
| title_full_unstemmed | Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient |
| title_short | Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient |
| title_sort | systemic reduced dose alteplase for diffuse pulmonary thrombi in a covid 19 patient |
| topic | alteplase computed tomography COVID‐19 diffuse pulmonary microthrombi pulmonary embolism |
| url | https://doi.org/10.1002/ccr3.7116 |
| work_keys_str_mv | AT yucelcolkesen systemicreduceddosealteplasefordiffusepulmonarythrombiinacovid19patient |